Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan

被引：0
|
作者：
Onda, T
Tanaka, T
Takeda, O
Kitagawa, M
Kuwabara, Y
Yamamoto, H
Iinuma, K
Shimomura, K
机构：
[1] Jikei Univ, Sch Med, Dept Obstet & Gynaecol, Tokyo 105, Japan
[2] Fuji City Hosp, Fuji, Shizuoka, Japan
[3] Natl Ohkura Hosp, Tokyo, Japan
[4] Juntendo Univ, Sch Med, Tokyo 113, Japan
[5] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan
[6] IG Clin, Tokyo, Japan
[7] Genzyme Japan KK, Tokyo, Japan
来源：
PRENATAL DIAGNOSIS | 1998年 / 18卷 / 09期
关键词：
triple-marker screening test; Down syndrome; prediction; accuracy; follow-up study;
D O I：
10.1002/(SICI)1097-0223(199809)18:9<956::AID-PD370>3.0.CO;2-R
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Based on 9350 pregnant Japanese women who were screened by serum triple-marker determination, accuracy of predicted risk for Down syndrome was examined using 24 Down syndrome cases detected either prenatally or postnatally. The correlation is statistically very high (r=0.98) between the predicted risks and the prevalence of Down syndrome cases. Here we emphasize that this could be accomplished only by an extensive follow-up study, implemented in our prospective intervention programme. (C) 1998 John Wiley & Sons, Ltd.
引用
收藏
页码：956 / 958
页数：3
相关论文
共 50 条
  • [1] Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
    Prefumo, F
    Thilaganathan, B
    PRENATAL DIAGNOSIS, 2002, 22 (10) : 917 - 918
  • [2] Triple-marker screening for Down syndrome - Response
    Dick, PT
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1996, 155 (03) : 272 - 273
  • [3] Second-trimester Down's syndrome serum screening: double, triple or quadruple marker testing?
    Harrison, G
    Goldie, D
    ANNALS OF CLINICAL BIOCHEMISTRY, 2006, 43 : 67 - 72
  • [4] ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome
    Christiansen, Michael
    Spencer, Kevin
    Laigaard, Jennie
    Cowans, Nicholas J.
    Larsen, Severin Olesen
    Wewer, Ulla M.
    PRENATAL DIAGNOSIS, 2007, 27 (07) : 611 - 615
  • [5] Accuracy of expected risk of Down syndrome using the second-trimester triple test
    Meier, C
    Huang, TH
    Wyatt, PR
    Summers, AM
    CLINICAL CHEMISTRY, 2002, 48 (04) : 653 - 655
  • [6] Role of second-trimester ultrasound in screening for Down syndrome
    Cuckle, H.
    Maymon, R.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (03) : 241 - 244
  • [7] Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome
    Muller, F
    Dreux, S
    Lemeur, A
    Sault, C
    Desgrès, J
    Bernard, MA
    Giorgetti, C
    Lemay, C
    Mirallié, S
    Beauchet, A
    PRENATAL DIAGNOSIS, 2003, 23 (13) : 1073 - 1076
  • [8] Second-trimester maternal serum invasive trophoblast antigen: A marker for down syndrome screening
    Pandian, R
    Cole, LA
    Palomaki, GE
    CLINICAL CHEMISTRY, 2004, 50 (08) : 1433 - 1435
  • [9] Combined first- and second-trimester screening for Down syndrome: an evaluation of proMBP as a marker
    Rode, L
    Wojdemann, KR
    Shalmi, AC
    Larsen, SO
    Sundberg, K
    Norgaard-Pedersen, B
    Christiansen, M
    Tabor, A
    PRENATAL DIAGNOSIS, 2003, 23 (07) : 593 - 598
  • [10] The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies
    Wan, Xiaohua
    Wen, Jiangping
    Song, Xin
    Guo, Yongjun
    Liu, Xiangyi
    Yang, Benshan
    Lu, Xinxin
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 (08): : 642 - 647
12345